A non-corporate government. As you either don’t understand the difference between what we have now and what it ought to be OR you don’t want to mention it because it goes against your beliefs and that cannot be challenged.
I thought you said the government has done a lot for the opioid crisis?
Does that make it right? To keep medicinal cannabis trapped in Schedule 1 and prevent studies on the substance. Funny how it’s been legalized in over half the states w/o that vaunted studies that give you a hard-on. From a person who pretends to be indifferent to pharma but defends their policies at any chance he gets. Supporting policies that make the public suffer. You must be so proud of yourself.
More anecdotal evidence or results. But I’m sure they are lying or they just experienced a placebo.
Spoiler, this talks about the national overdoses where close to half of the country’s states have not legalized cannabis. Do you think this could have made a difference? If every state had legalized cannabis would the stats be the same? This doesn’t refer to the lower number of overdoses in states that have legalized cannabis.
In regards to cannabis and opiods and the pharma stance.
“To them it’s competition for chronic pain, and that’s outrageous because we don’t have the crisis in people who take marijuana for chronic pain having overdose issues,” Sen. Kirsten Gillibrand of New York said. “It’s not the same thing. It’s not as highly addictive as opioids are.”
You don’t say. Gotta make that money. Who has time to worry about destroying the health of the population when there is cash to be made. Gotta love the for-profit healthcare system in America. A beacon to all in this world. Except it is showing how it shouldn’t be done. An exorbitant cost with mediocre outcomes at best. Something to be proud of.
And what if it were legalized in every state? Would the overdose deaths fall? And you think that someone as old as you are would figured to give this consideration. But no, your ideology comes first.
Sorry bud, gotta throw my 2 cents in here eh.
American Helth cafe May not the beacon you want it to be but I hear it is a helluva lot better than up here. Health Canada and the NHS haven’t stopped addictions any more than the USA’s lack of socialism has.
Or so it seems.
The problem with prescription drugs is simple: The U.S. government bestows long-term monopolies on pharmaceutical companies, immunizing them from the forces of market competition and public regulation. As a result, Americans shoulder the highest drug prices in the world while receiving significantly poorer public health outcomes than most of the developed world.
Pharmaceutical firms typically argue that long-term monopolies are necessary to justify the money they spend on research and development. And major drug companies do spend billions of dollars a year on R&D ― but not nearly as much as they spend on marketing, meaning that most of the costs recouped by monopoly profits aren’t essential to groundbreaking science. Nearly all research funded by pharmaceutical companies, moreover, piggybacks on government-backed research conducted by the National Institutes of Health. One study published earlier this year concluded that every one of the 210 new drugs approved by the FDA between 2010 and 2016 relied on at least some government-funded research, reflecting over $100 billion of public investment. Gasp!
Oh no! Look at who has the most contributions from lobbyists. I’m sure they are just doing it for fun and not as a R.O.I.
" While disappointing, it is important to put these numbers into perspective. According to EvaluatePharma , in 2017 the top 20 pharmaceutical companies invested 20.9% of top line revenues into R&D – a very impressive number. This amounted to $97.2 billion in 2017. For comparison purposes, the NIH budget is $37 billion. In 2024, EvaluatePharma is projecting that the top 20 companies will be spending $116.4 billion on R&D, 16.9% of sales – still a very high percentage when compared to other industries. The 2024 leaders will be Roche at $11.7B, Johnson & Johnson at $10.0B and Novartis at $9B."